ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals, Inc. (ANIP) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $70.93, up 0.06% on the day, which values the company at $1.61B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$70.93+0.06% today
Market value
$1.61B
P/E ratio
14.1×last 12 months
Forward P/E
7.0×
Funk Score
72/100
Against its own history
Well below its usual priceusual price $141.73
200-week average
$65.379% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

ANI Pharmaceuticals, Inc. in more detail

ANIP trades at 14.1× its last twelve months' earnings, 7.0× next year's expected earnings, 1.5× sales. Measured against its own history, the price is 50% below what its usual multiples would imply ($141.73) — well below its usual price. It sits 9% above its 200-week average of $65.37.

Over the last five fiscal years ANI Pharmaceuticals, Inc. has compounded revenue 33.5% a year, free cash flow 75.2% a year. Its Funk Score is 72 out of 100 (financial strength 4.1, profitability 5.7, growth 10.0, value 8.9, each out of 10).

In its favour: Strong Piotroski score; Five straight years of revenue growth. Worth checking: Share count keeps rising.

ANI Pharmaceuticals, Inc. (ANIP): questions and answers

What is ANIP's P/E ratio?

ANI Pharmaceuticals, Inc. trades at 14.1× its last twelve months' earnings and 7.0× next year's expected earnings. At its fiscal year-ends over the past 7 years the P/E ranged from 21.8× to 178.3×, with a median of 34.6×.

What is ANIP's PEG ratio?

ANI Pharmaceuticals, Inc.'s PEG ratio is 1.76 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is ANI Pharmaceuticals, Inc.'s market cap?

ANI Pharmaceuticals, Inc. is valued at $1.61B at a share price of $70.93.

Is ANIP overvalued or undervalued?

Against its own history, ANIP is well below its usual price: the price is 50% below the $141.73 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ANIP above its 200-week moving average?

Yes. ANIP is 8.5% above its 200-week average of $65.37. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is ANI Pharmaceuticals, Inc. growing?

Over the last five fiscal years ANI Pharmaceuticals, Inc.'s revenue grew 33.5% a year; over ten years revenue grew 27.7% a year.

Cite this page

Funkfolio, “ANI Pharmaceuticals, Inc. (ANIP) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ANIP

Underlying data: Yahoo Finance; company filings with the SEC.